work experienceAllison Kirschenmann started working in the field of neurobiology in 1986 with a study on neuronal growth factors in neurons. Graduate work in neuroscience led to teaching introductory biology and neurobiology, and publishing a series of papers on the physiology of intracellular calcium and neuronal calcium channels. Postdoctoral work on the pharmacology, molecular biology and physiology of cardiac and skeletal muscle calcium channels led to her first faculty position in 1998. She moved to the biotech industry in 2000 to direct a pharmacology research laboratory focusing on antiarrhythmics and help direct a clinical program on congestive heart failure and hyperuricemia. Additional clinical work involved assisting in the design and funding of clinical studies in rheumatology and neuropathic pain. She began lecturing in pharmacology at UBC in 2000 and anatomy, physiology, pathophysiology, neurology, and neuroscience at BCIT in 2007. She became a member of the BCIT Research Ethics Board in 2012 and has served as chair since 2015.
Ph.D., Neuroscience, University of Southern California, 1993
Channelopathies, neurology and neuroscience, pharmaceutical and medical device discovery and development.